Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ARMONICA TECHNOLOGIES, INC.
- Proposal award date
- 2022-08-11
- Contract end date
- 2024-07-31
- UEI
- Y8QBJM8BZSL5
- Solicitation number
- PA21-259
- Topic code
- 172
Research abstract
Single molecule DNA/RNA transport and Raman sequencing technology based on parallel Ramanscattering readout in a coupled nanochannel/nanopore system.
Abstract
Armonica Technologies, Inc. is proposing to develop a novel, high-throughput, label-free, highly
accurate, long-read DNA sequencing platform based on inexpensive nanoscale patterning and self-
assembly. The platform consists of nanochannels (cross section dimensions of ~ 100nm); tortuous
(convoluted 3D) nanopores formed by self-assembly of colloidal nanoparticles; nanoparticle barriers
placed across the nanochannels; and a metal-insulator-metal (MIM) field enhancement structure atop the
nanochannel roof. In operation, single- stranded- or double-stranded-DNA is partially stretched into a
linear configuration in the nanochannels, is blocked at barriers incorporated into the channels and forced
(by electric field) to translocate through the tortuous nanopores in the roof. The MIM structure on the roof
locally enhances the electromagnetic fields of applied laser sources allowing surface enhanced coherent
anti-Stokes Raman scattering (SECARS) detection of individual bases as they pass through the
electromagnetic hot spots, thus providing single base sensitivity and spatial localization. The distinct
Raman spectra of the individual bases and epigenetic variants allow label-free sequencing. Optical
detection allows massively parallel operation since the only requirement is separation of the pores by
more than an optical wavelength, easily accomplished in the fabrication. An important feature of the
platform is that the porous roofs allow introduction of oligonucleotides, small proteins, and DNA-
binding/DNA-processing enzymes, permitting optional manipulation and modification of the DNA in the
nanochannels. The goals of this Phase II project are: to develop a protocol for electrophoretic control of
the ssDNA translocation; to engineer the structure to ensurethat the ssDNA passes the MIM hot spot; to
sequence a short section of ssDNA and evaluate error rates; and to develop parallel optical readout, AI
analysis of the data and appropriate storage protocol.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
2 SBIR/STTR records share this UEI (2021–2022). Reported award amounts total $2,201,864. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards